Memory Beta, non-canon Star Trek Wiki

A friendly reminder regarding spoilers! As always, the expanded Trek universe is in a period of major upheaval with the continuations of Strange New Worlds and Prodigy, the advent of new eras in gaming with the Star Trek Adventures RPG and Star Trek Online, as well as other eventful releases such as Section 31, the ongoing IDW Star Trek comic and spin-off Star Trek: Defiant. Therefore, please be courteous to other users who may not be aware of current developments by using the {{spoiler}}, {{spoilers}} OR {{majorspoiler}} tags when adding new information from sources less than six months old (even if it is minor info). Also, please do not include details in the summary bar when editing pages and do not anticipate making additions relating to sources not yet in release. THANK YOU

READ MORE

Memory Beta, non-canon Star Trek Wiki
Ggramphud-1e

Ggramphud Histo-Cryogenics, Incorporated was a 23rd century business, a leading Tellarite medical corporation in that era.

History and specifics[]

Ggramphud

The corporation was privately founded in the mid-2240s decade, on reference stardate 2/8807.7. Based on Tellar, the Federation Science Foundation provided research funding for the firm to develop life prolongation techniques with cryogenics. (FASA RPG module: The Federation)

It was a leader in cellular medicine. Its pharmaceutical division provided additional funds for cryothermic treatment studies. (FASA RPG module: Trader Captains and Merchant Princes)

Dirg Ggramphud's son Arrv Ggramphud rejoined the company in 2270 after serving as a decorated Starfleet officer, replacing retiring second vice president Biq Downggil. Arrv rose to the position of company CEO by the 2280s. (Stardate Magazine vol. 1, Issue 5/6: "Making Your First Million")

By the 2280s, the firm's super-cold regimens supplanted a number of drug treatments. (FASA RPG module: Star Trek IV Sourcebook Update)

Finances[]

Stardate Stocks traded Closing price Net change
2/1103.01 773,000 53.90 +4.90
8402.3 803,000 56.60 +2.70
2/1104.11 149 53.20 0
2/1105.28 916,000 53.20 -3.40
2/2306.01 53.10

(Stardate Magazine, vol. 1, Issues 1, 2, 3/4, 5/6: "Making Your First Million")

As of the late 2280s, on reference stardate 2/2306.01, Ggramphud Histo-Cryogenics reported 926 million credits in assets, 112 million in liabilities, and 112 million in available cash. It held a stock profile of 3C36. (FASA RPG module: The Federation)

Key personnel[]

Appendices[]

References[]